Allergy Therapeutics plc (LON:AGY - Get Free Report)'s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 7.20 ($0.10) and traded as high as GBX 8.10 ($0.11). Allergy Therapeutics shares last traded at GBX 8.10 ($0.11), with a volume of 260,751 shares changing hands.
Allergy Therapeutics Stock Performance
The company has a debt-to-equity ratio of 835.48, a current ratio of 1.63 and a quick ratio of 1.48. The stock has a market capitalization of £405.49 million, a price-to-earnings ratio of -7.95, a PEG ratio of -30.70 and a beta of 1.40. The business has a 50 day simple moving average of GBX 7.27 and a 200-day simple moving average of GBX 6.80.
About Allergy Therapeutics
(
Get Free Report)
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Further Reading
Before you consider Allergy Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allergy Therapeutics wasn't on the list.
While Allergy Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
